Evolus (EOLS) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free EOLS Stock Alerts $13.59 -0.11 (-0.80%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Evolus Short Interest DataCurrent Short Volume4,780,000 sharesPrevious Short Volume4,640,000 sharesChange Vs. Previous Month+3.02%Dollar Volume Sold Short$56.26 millionShort Interest Ratio / Days to Cover7.7Last Record DateApril 30, 2024Outstanding Shares62,600,000 sharesFloat Size49,340,000 sharesShort Percent of Float9.69%Today's Trading Volume712,100 sharesAverage Trading Volume642,621 sharesToday's Volume Vs. Average111% Short Selling Evolus ? Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEOLS Short Interest Over TimeEOLS Days to Cover Over TimeEOLS Percentage of Float Shorted Over Time Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Evolus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,780,000 shares $56.26 million +3.0%9.7%7.7 $11.77 4/15/20244,640,000 shares $55.17 million -0.2%9.6%8.1 $11.89 3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00 3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90 2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83 2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77 Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69 1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55 12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53 12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90 11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47 11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91 10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60 10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14 9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14 9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44 8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89 8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20 7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02 7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40 6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27 6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69 5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05 5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32 4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74 4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39 3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46 3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56 2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07 2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37 1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39 1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65 12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51 12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02 11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24 11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54 10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56 10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33 9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05 9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.1641 banks launch ‘crypto dollar’ (Ad)Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). EOLS Short Interest - Frequently Asked Questions What is Evolus' current short interest? Short interest is the volume of Evolus shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,780,000 shares of EOLS short. 9.69% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest. What is a good short interest ratio for Evolus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 8.0. Learn More on Evolus's short interest ratio. Which institutional investors are shorting Evolus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolus: PEAK6 Investments LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Evolus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.69% of Evolus' floating shares are currently sold short. Is Evolus' short interest increasing or decreasing? Evolus saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,780,000 shares, an increase of 3.0% from the previous total of 4,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evolus' float size? Evolus currently has issued a total of 62,600,000 shares. Some of Evolus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evolus currently has a public float of 49,340,000 shares. How does Evolus' short interest compare to its competitors? 9.69% of Evolus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Evolus: Arcturus Therapeutics Holdings Inc. (20.02%), Longboard Pharmaceuticals, Inc. (13.02%), ALX Oncology Holdings Inc. (11.46%), Tango Therapeutics, Inc. (19.84%), Disc Medicine, Inc. (12.97%), Praxis Precision Medicines, Inc. (5.06%), Dianthus Therapeutics, Inc. (9.95%), Zentalis Pharmaceuticals, Inc. (24.64%), Pliant Therapeutics, Inc. (12.51%), PureTech Health plc (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Evolus stock? Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evolus? A short squeeze for Evolus occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further. How often is Evolus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Arcturus Therapeutics Short Squeeze Longboard Pharmaceuticals Short Squeeze ALX Oncology Short Squeeze Tango Therapeutics Short Squeeze Disc Medicine Short Squeeze Praxis Precision Medicines Short Squeeze Dianthus Therapeutics Short Squeeze Zentalis Pharmaceuticals Short Squeeze Pliant Therapeutics Short Squeeze PureTech Health Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EOLS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders